Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.52
-0.02 (-0.19%)
At close: Oct 28, 2026, 4:00 PM EDT
10.45
-0.07 (-0.67%)
Pre-market: Oct 29, 2026, 7:48 AM EDT

Corvus Pharmaceuticals Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho Securities
Mizuho Securities
Buy
Reiterates
$30
BuyReiterates$30+185.17%Aug 11, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$27
BuyMaintains$27+156.65%Aug 10, 2026
Oppenheimer
Oppenheimer
Buy
Reiterates
$33
BuyReiterates$33+213.69%Aug 7, 2026
Barclays
Barclays
Buy
Maintains
$28
BuyMaintains$28+166.16%Aug 7, 2026
Goldman Sachs
Goldman Sachs
Buy
Maintains
$40
BuyMaintains$40+280.23%May 15, 2026